Skip to content
Screener

Solventum SOLV Shares (Diluted)

Shares (Diluted) at other companies

3M logo
3MMMM
522.4M-3.4%
Sanara MedTech Inc. logo
Sanara MedTech Inc.SMTI
9M+4.9%
Cardinal Health logo
Cardinal HealthCAH
236M-2.1%
UnitedHealth Group logo
UnitedHealth GroupUNH
910M-0.9%
DENTSPLY SIRONA logo
DENTSPLY SIRONAXRAY
200.5M+0.6%
Align Technology logo
Align TechnologyALGN
71.5M-1.5%

Other financials

Income statement

See full
Revenue$2.2B+2.2%
Gross profit$1.3B+9.4%
Operating income$181.0M-15.4%
Net income$92.0M+2.2%
EPS (diluted)$0.53+3.9%

Balance sheet

See full
Cash & equivalents$403.0M-18.1%
Total debt$5.8B-25.9%
Total equity$4.8B+31.7%
Total assets$14.2B-5.5%

Cash flow

See full
Operating cash flow$227.0M+34.3%
CapEx$83.0M-24.5%
Free cash flow-$273.0M-241%

Valuation

See full
Market cap$15.15B+20.6%
Enterprise value$20.54B+3.3%
P/E10.6×-22.5×
P/S1.8×+0.3×

Profitability

See full
Gross margin54.7%+0.2pp
Operating margin25%+15.7pp
Net margin17.3%+12.7pp
FCF margin4.6%-13.9pp

Returns & leverage

See full
Return on equity34%+22.3pp
Debt / equity1.2×-0.9×
Current ratio-0.2×

Where this comes from

Reported directly by Solventum in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding.

The source filing: Solventum’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 5:27 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001964738-26-000047
(Millions, except per share data)Three months ended June 30, 2026Three months ended June 30, 2025Six months ended June 30, 2026Six months ended June 30, 2025
Provision for (benefit from) income taxes151319(86)
Net income$92$90$105$227
Earnings per share:
Basic earnings per share$0.53$0.52$0.60$1.31
Diluted earnings per share0.530.510.601.30
Weighted-average number of shares outstanding:
Basic172.7174.1173.5173.9
Diluted173.3175.2174.4175.0

Item 1. Financial Statements

FAQ

What is Solventum's shares (diluted)?
Solventum (SOLV) reported shares (diluted) of 173.3M in Q2 2026.
How has Solventum's shares (diluted) changed year-over-year?
Solventum's shares (diluted) decreased by 1.1% year-over-year, from 175.2M to 173.3M.
What is the long-term trend for Solventum's shares (diluted)?
Over 2 years (2023 to 2025), Solventum's shares (diluted) has grown at a 0.7% compound annual growth rate (CAGR), from 690.8M to 700.7M.
What does shares (diluted) mean?
The weighted-average shares outstanding plus all potentially dilutive shares from stock options, RSUs, convertible securities, and warrants, using the treasury stock method.

Ask your AI about Solventum's shares (diluted).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude